Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atomoxetine Effects in Methamphetamine Dependence
NCT02014064Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Aug 2009
- Primary completion
- Aug 2012
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Atomoxetine with Placebo (2 arms). Primary endpoint: Cardiovascular & Subjective Effects of Methamphetamine & Atomoxetine at 4 weeks. Started Aug 2009; status: completed.
02
Drugs
atomoxetine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT02014064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02014064.